local_hospital

Clínica Dermatología y Alergia

Address
Calle Muñoz Torrero, 21, 06001 Badajoz, Spain

Clínica Dermatología y Alergia

Clínica Dermatología y Alergia is a specialized medical research center dedicated to advancing the treatment of allergic conditions through clinical investigation. The center focuses on developing and evaluating innovative therapeutic approaches for patients suffering from respiratory allergic diseases, with particular expertise in allergen immunotherapy and the management of complex allergic presentations.

  • Dust mite allergy treatment and vaccine development
  • Moderate-severe allergic rhinitis and rhinoconjunctivitis according to ARIA classification
  • Controlled mild-moderate allergic asthma management in combination with rhinitis

The center specializes in evaluating subcutaneous polymerized allergen extracts as an etiological treatment approach for patients with intermittent or persistent allergic conditions. Their research portfolio emphasizes evidence-based interventions for patients presenting with combined respiratory allergic manifestations, aligning with international guidelines such as GEMA 5.0 for asthma management and ARIA classifications for rhinitis severity assessment.

Site Overview

assignment
5
connected trials
corporate_fare
2
sponsors
science
16
IMPs

Activity Indicator

Last 6 months

2
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_upGrowing+100%
2
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 2 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 567 other sites in Spain

description
Trial volume
5
Outperforms 66% of sites
public
Therapeutic diversity
2areas
Outperforms 49% of sites
groups
Sponsor diversity
2sponsors
Outperforms 49% of sites

Therapeutic Area Benchmark — Spain

Select a therapeutic area to compare against other sites in Spain.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Spain

Market Share

Country: Spain

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Clínica Dermatología y Alergia

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety of Depigmented Polymerized Grass Pollen Extracts in Patients with Allergic Rhinoconjunctivitis and Controlled Asthma: A Randomized Controlled TrialLETI Pharma S.L.U.Phase IIIRecruitingJun 2026

IMP list

lock Showing 1 of 16 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Dactylis Glomerata Pollen Extract2Unknown2026-06-232026-06-23

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.